Ercan, A. Et Al. 2010. Aberrant IgG Galactosylation Precedes Disease Onset, Correlates With Disease Activity, and Is Prevalent in Autoantibodies in Rheumatoid Arthritis. ARTHRITIS AND RHEUMATISM , vol.62, no.8 , 2239-2248.

Ercan, A., Cui, J., Chatterton, D. E. W., Deane, K. D., Hazen, M. M., Brintnell, W., ... O'Donnell, C. I.(2010). Aberrant IgG Galactosylation Precedes Disease Onset, Correlates With Disease Activity, and Is Prevalent in Autoantibodies in Rheumatoid Arthritis. ARTHRITIS AND RHEUMATISM , vol.62, no.8, 2239-2248.

Ercan, ALTAN Et Al. "Aberrant IgG Galactosylation Precedes Disease Onset, Correlates With Disease Activity, and Is Prevalent in Autoantibodies in Rheumatoid Arthritis," ARTHRITIS AND RHEUMATISM , vol.62, no.8, 2239-2248, 2010

Ercan, ALTAN Et Al. "Aberrant IgG Galactosylation Precedes Disease Onset, Correlates With Disease Activity, and Is Prevalent in Autoantibodies in Rheumatoid Arthritis." ARTHRITIS AND RHEUMATISM , vol.62, no.8, pp.2239-2248, 2010

Ercan, A. Et Al. (2010) . "Aberrant IgG Galactosylation Precedes Disease Onset, Correlates With Disease Activity, and Is Prevalent in Autoantibodies in Rheumatoid Arthritis." ARTHRITIS AND RHEUMATISM , vol.62, no.8, pp.2239-2248.

@article{article, author={ALTAN ERCAN Et Al. }, title={Aberrant IgG Galactosylation Precedes Disease Onset, Correlates With Disease Activity, and Is Prevalent in Autoantibodies in Rheumatoid Arthritis}, journal={ARTHRITIS AND RHEUMATISM}, year=2010, pages={2239-2248} }